ArticleThe oncologist2024

Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade.

Rong Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.